Pharmacokinetic study of artemether–lumefantrine given once daily for the treatment of uncomplicated multidrug‐resistant falciparum malaria
Open accessThe DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Summary: Background Adherence to antimalarial drug regimens is improved by simple dosing. If the fixed antimalarial drug combination artemether–lumefantrine (AL) could be given once daily, this should improve adherence and thus effectiveness and lower the risk of selecting for resistance. Methods In an open randomized study, 43 patients with uncomplicated falciparum malaria were given equivalent doses of AL with 200 ml flavoured milk either as the conventional twice‐daily regimen or as a single daily dose for 3 days. The primary end point was a comparison of the areas under the plasma lumefantrine concentration–time curves (AUC). Secondary end points were the day 42 polymerase chain reaction (PCR)‐adjusted cure rates and the tolerability profiles. Results Lumefantrine pharmacokinetic profiles were obtained for 36 patients. The AUC(0→∞) of the once‐daily regimen was 30% lower than that in the conventional regimen (P = 0.011) with a median (range) value of 306 (114–5781) μ g/ml h, compared with 432 (308–992) μ g/ml h. There was no significant difference in the peak plasma concentrations reached. PCR‐adjusted cure rate estimates at day 42 of follow‐up were 94% (95% CI: 84–100) in the six‐dose arm and 85% (70–100) in the three‐dose arm (P = 0.3). Conclusion Artemether–lumefantrine efficacy is reduced by once‐daily dosing, because absorption of lumefantrine is dose limited. At currently recommended doses, this antimalarial should be given twice daily in a 3‐day regimen, with food containing fat.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nosten, F., van Vugt, M., Price, R., Luxemburger, C., Thway, K., Brockman, A., McGready, R., ter Kuile, F., Looareesuwan, S., & White, N. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02505-8 · Cited by 500
Self-citationThe epidemiology of malaria in a Karen population on the western border of Thailand.
Luxemburger, C., Thwai, K. L., White, N. J., Webster, H. K., Kyle, D. E., Maelankirri, L., Chongsuphajaisiddhi, T., & Nosten, F. (1996) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/s0035-9203(96)90102-9 · Cited by 233 · cited 3×
“The epidemiology of malaria in this area and the effect of introducing ACT have been described in detail by Luxemburger et al. (1996) and Nosten et al.”
BackgroundSelf-citationHow do patients use antimalarial drugs? A review of the evidence
Yeung, S., & White, N. J. (2005) · Tropical Medicine & International Health · doi:10.1111/j.1365-3156.2004.01364.x · Cited by 124
Self-citation
Cited by
Artemisinin-Based Combination Treatment of Falciparum Malaria
Nosten, F., & White, N. J. (2007) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2007.77.181 · Cited by 673
Self-citationWorldWide Antimalarial Resistance Network (WWARN) Lumefantrine PK/PD Study Group (2015) · BMC Medicine · doi:10.1186/s12916-015-0456-7 · Cited by 464
McGready, R., Tan, S. O., Ashley, E. A., Pimanpanarak, M., Viladpai-nguen, J., Phaiphun, L., Wüstefeld, K., Barends, M., Laochan, N., Keereecharoen, L., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050253 · Cited by 136
“A major drawback is that lumefantrine absorption has been shown to be dose-limited [47], so simply increasing the individual doses is unlikely to result in higher cure rates.”
BackgroundSelf-citationMcGready, R., Stepniewska, K., Lindegardh, N., Ashley, E. A., La, Y., Singhasivanon, P., White, N. J., & Nosten, F. (2006) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-006-0199-7 · Cited by 115
Self-citationLarsen, D. A., Bennett, A., Silumbe, K., Hamainza, B., Yukich, J. O., Keating, J., Littrell, M., Miller, J. M., Steketee, R. W., & Eisele, T. P. (2015) · The American Society of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.14-0347 · Cited by 108
Metadata
- Authors
- Ashley, E. A., Stepniewska, K., Lindegårdh, N., McGready, R., Annerberg, A., Hutagalung, R., Singtoroj, T., Hla, G., Brockman, A., Proux, S., Wilahphaingern, J., Singhasivanon, P., White, N. J., & Nosten, F.
- Venue
- Tropical Medicine & International Health
- Publisher
- Wiley
- Published
- 2007-01-18
- Volume
- 12
- Issue
- 2
- Pages
- 201-208
- ISSN
- 1360-2276 (ISSN-L)
- 1365-3156
- OpenAlex
- W1525415484
- Cited by
- 101
- References
- 3
- FWCI
- 6.72
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pharmacokinetic study of artemether–lumefantrine given once daily for the treatment of uncomplicated multidrug‐resistant falciparum malaria. https://app.cochat.ai/papers/10.1111/j.1365-3156.2006.01785.x
- The paper
- Ashley, E. A., Stepniewska, K., Lindegårdh, N., McGready, R., Annerberg, A., Hutagalung, R., Singtoroj, T., Hla, G., Brockman, A., Proux, S., Wilahphaingern, J., Singhasivanon, P., White, N. J., & Nosten, F. (2007). Pharmacokinetic study of artemether–lumefantrine given once daily for the treatment of uncomplicated multidrug‐resistant falciparum malaria. Tropical Medicine & International Health. https://doi.org/10.1111/j.1365-3156.2006.01785.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.